Who Just RaisedMonrovia, MD · Health Care · Form D filed Oct 7, 2026
Monocacy Therapeutics Inc. raised $25K
Monocacy Therapeutics Inc. is a biotechnology company based in Monrovia, Maryland. In a Form D filed with the SEC on October 7, 2026, it reported raising $25,000 from 1 investor as part of an offering of up to $25,000. The first sale in the offering took place on September 25, 2026.
- 5th Form D since 2026. Earlier new notices: Sep 21, 2026 · Aug 28, 2026 · Aug 28, 2026 · May 27, 2026. All filings on EDGAR
$414K raised since 2020
5 Form D offerings, as reported to the SEC, the first in May 27, 2026. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 7, 2026 | $25K | $25K | 1 |
| Sep 21, 2026 | $49 | $49 | 1 |
| Aug 28, 2026 | $150K | $150K | 1 |
| Aug 28, 2026 | $125K | $125K | 5 |
| May 27, 2026 | $114K | Open | 2 |
Lead score
17 out of 100
filed recently young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $25,000
- Offering size
- $25,000
- Investors so far
- 1
- First sale
- September 25, 2026
- Securities offered
- Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Monrovia, Maryland
- Incorporated
- Delaware, 2025
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $25,000 | $25,000 | 1 | SEC filing | |
| D (new notice) | $49 | $49 | 1 | SEC filing | |
| D (new notice) | $150,000 | $150,000 | 1 | SEC filing | |
| D (new notice) | $125,000 | $125,000 | 5 | SEC filing | |
| D/A (amendment) | $114,450 | Indefinite | 2 | SEC filing |
Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Oct 5, 2026 · Health Care funding in Maryland
Similar raises
Kaigene, Inc.
Rockville, MD · filed Oct 142nd Form D since 2022Still raising
ColoWatch, Inc.
Gaithersburg, MD · filed Oct 8
Virtual colonoscopy screening with no sedation, standardized protocols, secure cloud delivery, advanced 3D visualization, and expert radiologist interpretation.
First Form DStill raising
Templar Nova, Inc.
Rockville, MD · filed Oct 7First Form D
Seraxis Holdings, Inc.
Germantown, MD · filed Sep 24
Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.
2nd Form D since 2021
Aromha, Inc.
Potomac, MD · filed Sep 243rd Form D since 2025
Uvantis Therapeutics, Inc.
Columbia, MD · filed Sep 23First Form DStill raising
Functional Longevity Labs, Inc.
Easton, MD · filed Sep 21First Form DStill raising
Gliknik Inc
Baltimore, MD · filed Sep 17
10th Form D since 2010